Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Valhi
VHI
$450M
| $880K | ﹤0.01% |
54,177
+818
| +2% | +$16K |
|
|
CNTA
3352
DELISTED
Centessa Pharmaceuticals
CNTA
| $869K | ﹤0.01% |
60,441
+3,184
| +6% | +$52.1K |
|
3353
Avalo Therapeutics
AVTX
$983M
| $864K | ﹤0.01% |
107,812
+2,959
| +3% | +$22.4K |
|
3354
Commercial Vehicle Group
CVGI
$147M
| $862K | ﹤0.01% |
749,447
+23,220
| +3% | +$44.9K |
|
3355
Sagimet Biosciences
SGMT
$559M
| $860K | ﹤0.01% |
263,724
+8,488
| +3% | +$35.6K |
|
3356
X4 Pharmaceuticals
XFOR
$460M
| $856K | ﹤0.01% |
120,656
+4,082
| +4% | +$56.2K |
|
|
ZYXI
3357
DELISTED
Zynex
ZYXI
| $852K | ﹤0.01% |
386,997
-56,023
| -13% | -$366K |
|
3358
SKYX Platforms
SKYX
$164M
| $846K | ﹤0.01% |
742,065
+29,674
| +4% | +$44.1K |
|
3359
Genelux
GNLX
$119M
| $846K | ﹤0.01% |
313,229
+9,911
| +3% | +$37.2K |
|
|
BLTE
3360
Belite Bio
BLTE
$6.54B
| $845K | ﹤0.01% |
12,753
+6,053
| +90% | +$365K |
|
3361
AirSculpt Technologies
AIRS
$353M
| $844K | ﹤0.01% |
361,341
+3,456
| +1% | +$15.5K |
|
3362
Metagenomi Therapeutics
MGX
$46.3M
| $843K | ﹤0.01% |
619,574
+32,153
| +5% | +$76.6K |
|
3363
Playboy Inc
PLBY
$141M
| $841K | ﹤0.01% |
763,980
+44,681
| +6% | +$69.8K |
|
|
MRSN
3364
DELISTED
Mersana Therapeutics
MRSN
| $841K | ﹤0.01% |
97,693
+3
| +0% | +$46 |
|
|
TPIC
3365
DELISTED
TPI Composites
TPIC
| $839K | ﹤0.01% |
1,040,509
+18,905
| +2% | +$24.7K |
|
|
GRFS
3366
Grifois
GRFS
$5.4B
| $832K | ﹤0.01% |
117,080
+5,408
| +5% | +$40.8K |
|
3367
MPLX
MPLX
$59.7B
| $831K | ﹤0.01% |
15,536
+388
| +3% | +$20.3K |
|
|
QVCGA
3368
DELISTED
QVC Group Inc Series A
QVCGA
| $831K | ﹤0.01% |
82,586
+5,235
| +7% | +$83.2K |
|
|
DCBO
3369
Docebo
DCBO
$566M
| $824K | ﹤0.01% |
28,683
-12,220
| -30% | -$462K |
|
|
OPTN
3370
DELISTED
OptiNose
OPTN
| $823K | ﹤0.01% |
89,684
+3,517
| +4% | +$22.1K |
|
|
CLYM
3371
Climb Bio
CLYM
$804M
| $822K | ﹤0.01% |
673,811
+12,980
| +2% | +$21.1K |
|
3372
Lightpath Technologies
LPTH
$820M
| $821K | ﹤0.01% |
408,168
+18,549
| +5% | +$51K |
|
|
MAG
3373
DELISTED
MAG Silver
MAG
| $820K | ﹤0.01% |
53,462
+3,374
| +7% | +$52.4K |
|
|
FFAI
3374
Faraday Future Intelligent Electric
FFAI
$10.5M
| $820K | ﹤0.01% |
4,837
+1,906
| +65% | +$428K |
|
|
AGEN
3375
Agenus
AGEN
$290M
| $819K | ﹤0.01% |
544,139
+68,553
| +14% | +$197K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.